[HTML][HTML] A guide to vaccinology: from basic principles to new developments

AJ Pollard, EM Bijker - Nature Reviews Immunology, 2021 - nature.com
Immunization is a cornerstone of public health policy and is demonstrably highly cost-
effective when used to protect child health. Although it could be argued that immunology has …

Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines

AJ Pollard, KP Perrett, PC Beverley - Nature Reviews Immunology, 2009 - nature.com
Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and
pneumonia in children. The use of protein–polysaccharide conjugate vaccines in developed …

Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

B Shi, L Sepp-Lorenzino, M Prisco, P Linsley… - Journal of Biological …, 2007 - ASBMB
The insulin receptor substrate-1 (IRS-1), a docking protein for both the type 1 insulin-like
growth factor receptor (IGF-IR) and the insulin receptor, is known to send a mitogenic, anti …

Advances in the Development of Vaccines against Neisseria meningitidis

LKK Tan, GM Carlone, R Borrow - New England Journal of …, 2010 - Mass Medical Soc
Neisseria meningitidis remains a leading cause of meningitis and sepsis. This review
provides an update on our understanding of immunity against meningococcal infection …

The design of semi-synthetic and synthetic glycoconjugate vaccines

P Costantino, R Rappuoli, F Berti - Expert Opinion on Drug …, 2011 - Taylor & Francis
Introduction: Glycoconjugate vaccines are among the safest and most efficacious vaccines
developed during the last 30 years. They are a potent tool for prevention of life-threatening …

Protein carriers for glycoconjugate vaccines: history, selection criteria, characterization and new trends

F Micoli, R Adamo, P Costantino - Molecules, 2018 - mdpi.com
Currently licensed glycoconjugate vaccines are composed of a carbohydrate moiety
covalently linked to a protein carrier. Polysaccharides are T-cell independent antigens able …

Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines

X Sun, G Stefanetti, F Berti… - Proceedings of the …, 2019 - National Acad Sciences
Glycoconjugate vaccines are among the most effective interventions for preventing several
serious infectious diseases. Covalent linkage of the bacterial capsular polysaccharide to a …

[HTML][HTML] Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants

TV Murphy, BA Slade, KR Broder, K Kretsinger… - MMWR Recomm …, 2008 - cdc.gov
In 2005, two tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap)
vaccines were licensed and recommended for use in adults and adolescents in the United …

Carriers and antigens: new developments in glycoconjugate vaccines

RMF van der Put, B Metz, RJ Pieters - Vaccines, 2023 - mdpi.com
Glycoconjugate vaccines have proven their worth in the protection and prevention of
infectious diseases. The introduction of the Haemophilus influenzae type b vaccine is the …

Recent mechanistic insights on glycoconjugate vaccines and future perspectives

F Berti, R Adamo - ACS Chemical Biology, 2013 - ACS Publications
Vaccination is a key strategy for the control of various infectious diseases. Many pathogens,
such as Streptococcus pneumoniae, Haemophilus influenzae type b (Hib), and Neisseria …